Filing Details
- Accession Number:
- 0001144204-13-014648
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-12 18:30:27
- Reporting Period:
- 2013-03-08
- Filing Date:
- 2013-03-12
- Accepted Time:
- 2013-03-12 18:30:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1006281 | Protalix Biotherapeutics Inc. | PLX | Biological Products, (No Disgnostic Substances) (2836) | 650643773 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434514 | Alfred Akirov | C/O Protalix Biotherapeutics, Inc. 2 Snunit Street Science Park, Pob 455 Carmiel L3 20100 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-08 | 10,000 | $5.82 | 5,062,911 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-08 | 2,500 | $5.91 | 5,060,411 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-08 | 2,500 | $5.92 | 5,057,911 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-08 | 1,898 | $5.95 | 5,056,013 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-11 | 300 | $5.79 | 5,055,713 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-11 | 3,000 | $5.75 | 5,052,713 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-11 | 10,000 | $5.72 | 5,042,713 | No | 4 | S | Indirect | By Corporation |
| Common Stock | Disposition | 2013-03-11 | 5,000 | $5.71 | 5,037,711 | No | 4 | S | Indirect | By Corporation |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
| No | 4 | S | Indirect | By Corporation |
Footnotes
- All sales reported on this Form 4 were made by Alrov (Israel) Ltd.("Alrov Israel") and the column in Table 1 disclosing the amount of securities beneficially owned following the reported transactions includes 686,046 shares of our common stock held by Technorov Holdings (1993) Ltd. ("Technorov"). Alrov Israel owns 100% of Al-Rov Technologies Holdings LTD, the holder of 80% of Technorov. The reporting person is the Chairman of Alrov Israel and the Chief Executive Officer of Technorov, and has the power to control their respective investment decisions. Alrov Israel is an Israeli publicly-traded company that is listed on the Tel Aviv Stock Exchange. Mr. Akirov disclaims beneficial ownership of the securities of the Issuer held by Alrov Israel and Technorov, except to the extent of his proportional pecuniary interest therein.
Billionaire Hedge Funds
